rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Jaguar Health, Inc.

JAGX · Nasdaq

Health CareBiotechnologyNot moving yet

JAGX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 94.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
7 (-2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders7-2 on the quarter
New · exited1 · 3
Reported value$16K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
UBS Group AGreduced · filed 13 Aug 20264,000$12K-108,906−96.5%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 20261,160$3,480-1,151−49.8%
SBI Securities Co., Ltd.reduced · filed 23 Jul 202684$252-2,487−96.7%
BARCLAYS PLCnew · filed 14 Aug 202656$168+56
WELLS FARGO & COMPANYreduced · filed 14 Aug 20265$15-195−97.5%
Leonteq Securities AGreduced · filed 27 Jul 20265$15-183−97.3%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLCreduced · filed 22 Jul 20261$3-44−97.8%
31 Mar 2023 – 30 Jun 2026
1611Mar 23Sep 24Jun 25Dec 25Jun 26

News

Everyone who traded it

Anula Jayasuriya Company insiderDirector · last 11 Dec 20250 · 0
Carol R. Lizak Company insiderChief Financial Officer · last 11 Dec 20251 · 0
James J. Bochnowski Company insiderDirector · last 11 Dec 20253 · 2
John Micek Company insiderDirector · last 11 Dec 20250 · 0
Jonathan B. Siegel Company insiderDirector · last 11 Dec 20256 · 0
Jonathan S. Wolin Company insiderOfficer · last 11 Dec 20251 · 0
Lisa A. Conte Company insiderDirector, Officer · last 11 Dec 20252 · 0
Pravin R. Chaturvedi Company insiderChief Scientific Officer · last 11 Dec 20250 · 0
Steven R. King Company insiderOfficer · last 11 Dec 20250 · 0
Gregory J. Divis Company insiderDirector · last 18 May 20220 · 0
Jeffery C. Johnson Company insiderDirector · last 24 Jul 20190 · 0
Karen Steil Wright Company insiderCFO and Treasurer · last 24 Jul 20190 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202567.2%
Operating profit marginFY 2025 · to 31 Dec 2025-399%
Free cash flow marginFY 2024 · to 31 Dec 2024-252%
Return on capital employedFY 2024 · to 31 Dec 2024-91.4%
Research spendFY 2025 · to 31 Dec 2025217%
Cash and equivalentsFY 2025 · to 31 Dec 2025$968K
Free cash flowFY 2024 · to 31 Dec 2024−$29.4M

Analyst forecasts

No analyst forecasts yet.